The reverse transcriptase enzymes market is projected to grow from USD 370.3 million in 2025 to USD 517.4 million by 2035, at a CAGR of 3.4%. Research Application will dominate with a 57.0% market share, while reagents application will lead the product type segment with a 48.0% share.